TIBER CREEK GROUP for EMD SERONO, INC.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Issues relating to Medicare Part D Price Reform. S. 2543 - The Prescription Drug Price Reduction Act. H.R. 3 - Lower Drug Costs Now Act of 2019. HR 6201 Families First Coronavirus Response Act (PL 116-27); CARES Act - S. 3548 (PL 116-136) - drug pricing issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JONATHON JONES | — |
| ASHLI PALMER New | Director of Floor Operations, Majority Whip James E. Clyburn; Policy Director, Assistant Democratic Leader James E. Clyburn; Chief of Staff, Rural Business Services Agency (USDA) |
Health Issues HCR
Issues relating to pharmaceutical pricing. Issues relating to drug development. S. 2543 - The Prescription Drug Price Reduction Act. H.R. 3 - Lower Drug Costs Now Act of 2019. HR 6201 Families First Coronavirus Response Act (PL 116-27); CARES Act - S. 3548 (PL 116-136) - drug pricing issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JONATHON JONES | — |
| ASHLI PALMER New | Director of Floor Operations, Majority Whip James E. Clyburn; Policy Director, Assistant Democratic Leader James E. Clyburn; Chief of Staff, Rural Business Services Agency (USDA) |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.